Suppression of CD44 expression decreases migration and invasion of human glioma cells

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 255-260

  Okada, Hideho ^a   Yoshida, Jun ^a   Sokabe, Masahiro ^a   Wakabayashi, Takashi ^a   Hagiwara, Masatoshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL MIGRATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; BRAIN NEOPLASMS; CELL MOVEMENT; GLIOMA; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029889923     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A     Document Type: Article

References (25)

1. ASHER, R. and BIGNAMI, A., Localization of hyaluronic acid in primary glial-cell cultures derived from newborn rat brain. Exp. Cell Res., 195, 401-411 (1991).
2. ASHER, R. and BIGNAMI, A., Hyaluronic acid binding and CD44 expression in human glioblastoma cells and astrocytes. Exp. Cell Res., 203, 80-90 (1992).
3. AZNAVOORIAN, S., STRACKE, M.L., KRUTZSCH, H., SCHIFFMAN, E. and LIOTTA, L.A., Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumour cells. J. Cell Biol., 110, 1427-1438 (1990).
4. ELICES, M.J., URRY, L.A. and HEMLER, M E., Receptor function for the integrin VLA-3: fibronectin, collagen and laminin binding are differentially influenced by ARG-GLY-ASP peptide and by divalent cations. J. Cell Biol., 112, 169-181 (1991).
5. GOODMAN, S.L., RISSE, G. and VON DER MARK, K., The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix. J. Cell Biol., 109, 799-809 (1989).
6. HART, I.R., BIRCH, M. and MARSHALL, J.F., Cell-adhesion-receptor expression during melanoma progression and metastasis. Cancer Metast. Rev., 10, 115-128 (1991).
7. HERRLICH, P., GUNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZOLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A. and PONTA, H.A., New variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
8. KOSHIZAKA, T., HAYASHI, Y. and YAGI, K., Novel liposomes for efficient transfection of β-galactosidase gene into COS-1 cells. J. clin. Biochem. Nutr., 7, 185-192 (1989).
9. KUPPNER, M.C., VAN MEIER, E.G., GAUTHIER, T., HAMOU, M.F. and DE TRIBOLET, N., Differential expression of the CD44 molecule in human brain tumours. Int. J. Cancer, 50, 572-577 (1992).
10. LACY, B.E. and UNDERHILL, C.B., The hyaluronic-acid receptor is associated with actin filaments. J. Cell Biol., 105, 1395-1404 (1987).
11. LI, H., HAMOU, M.F., DE TRIBOLT, N., JAUFEERALLY, R., HOFMANN, M., DISERENS, A.C. and VAN MEIR, E.G., Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res., 53, 5345-5349 (1993).
12. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumour invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. (Suppl.), 51, 5054s-5059s (1991).
13. LOKESHWAR, V.B., FREGIEN, N. and BOURGUIGNON, L.Y., Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic-acid-mediated adhesion function. J. Cell Biol., 126, 1099-1109 (1994).
14. MACKAY, C.R., TERPE, H.J., STAUDER, R., MARSTON, W.L., STARK, H and GUNTHERT, U., Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124, 71-82 (1994).
15. MERZAK, A., KOOCHECKPOUR, S. and PILKINGTON, G.J., CD44 mediates human glioma-cell adhesion and invasion in vitro. Cancer Res., 54, 3988-3992 (1994).
16. OKADA, H., YOSHIDA, J., SEO, H., WAKABAYASHI, T., SUGITA, K. and HAGIWARA, M., Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes over-expressed CD44 in glioma cells. Cancer Immunol. Immunother., 39, 313-317 (1994).
17. PALS, S.T., HOGERVOST, F., KEIZER, G.D., THEPEN, T., HORST, E. and FIGDOR, C.C., Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J. Immunol., 143, 851-857 (1989).
18. RAO, J.S., STECK, P.A., MOHANAM, S., STETLER-STEVENSON, W.G., LIOTTA, L.A. and SAWAYA, R., Elevated levels of Mr 92,000 type-IV collagenase in human brain tumours. Cancer Res., 53, 2208-2221 (1993).
19. RUTKA, J.T., APODAKA, G., STERN, R. and ROSENBULM, M., The extracellular matrix of the central and peripheral nervous system: structure and function. J. Neurosurg., 69, 155-170 (1988).
20. SHTIVELMAN, E. and BISHOP, J.M., Expression of CD44 is repressed in neuroblastoma cells. Mol. cell. Biol , 11, 5446-5453 (1991).
21. SY, M.S., GUO, Y.J. and STAMENKOVIC, I., Distinct effects of two CD44 isoforms on tumour growth in vivo. J exp. Med., 174, 859-866 (1991).
22. THOMAS, L., BYERS, H.R., VINK, J. and STAMENKOVIC, I., CD44H regulates tumour-cell migration on hyaluronic-acid-coated substrate. J. Cell Biol., 118, 971-977 (1992).
23. TSUKITA, S., OISHI, K., SATO, N., SAGARA, J., KAWAI, A. and TSUKITA, S., ERM family members as molecular linkers between the cell-surface glycoprotein CD44 and actin based cytoskeletons J. Cell Biol., 126, 391-401 (1994).
24. WAKABAYASHI, T., YOSHIDA, J., SEO, H., KATO, K., MURATA, Y., MATUI, N. and KAGEYAMA, N., Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma. J. Neurosurg., 68, 449-455 (1988).
25. 123I-labeled monoclonal antibody G-22 against glioma-associated antigen. J. Neuro-Oncology, 8, 221-229 (1990).